title: Preferential elevation of Prx I and Trx expression in lung cancer cells following hypoxia and in human lung cancer tissues.
abstract: Transient/chronic microenvironmental hypoxia that exists within a majority of solid tumors has been suggested to have a profound influence on tumor growth and therapeutic outcome. Since the functions of novel antioxidant proteins, peroxiredoxin I (Prx I) and II, have been implicated in regulating cell proliferation, differentiation, and apoptosis, it was of our special interest to probe a possible role of Prx I and II in the context of hypoxic tumor microenvironment. Since both Prx I and II use thioredoxin (Trx) as an electron donor and Trx is a substrate for thioredoxin reductase (TrxR), we investigated the regulation of Trx and TrxR as well as Prx expression following hypoxia. Here we show a dynamic change of glutathione homeostasis in lung cancer A549 cells and an up-regulation of Prx I and Trx following hypoxia. Western blot analysis of 10 human lung cancer and paired normal lung tissues also revealed an elevated expression of Prx I and Trx proteins in lung cancer tissues. Immunohistochemical analysis of the lung cancer tissues confirmed an augmented Prx I and Trx expression in cancer cells with respect to the parenchymal cells in adjacent normal lung tissue. Based on these results, we suggest that the redox changes in lung tumor microenvironment could have acted as a trigger for the up-regulation of Prx I and Trx in lung cancer cells. Although the clinical significance of our finding awaits more rigorous future study, preferential augmentation of the Prx I and Trx in lung cancer cells may well represent an attempt of cancer cells to manipulate a dynamic redox change in tumor microenvironment in a manner that is beneficial for their proliferation and malignant progression.
authors.affiliation: Department of Internal Medicine, Yonsei University College of Medicine, Korea.
authors.forename: H J
authors.initials: HJ
authors.lastname: Kim
authors.forename: H Z
authors.initials: HZ
authors.lastname: Chae
authors.forename: Y J
authors.initials: YJ
authors.lastname: Kim
authors.forename: Y H
authors.initials: YH
authors.lastname: Kim
authors.forename: T S
authors.initials: TS
authors.lastname: Hwangs
authors.forename: E M
authors.initials: EM
authors.lastname: Park
authors.forename: Y M
authors.initials: YM
authors.lastname: Park
mesh_terms: D000975:Antioxidants / Q000494:pharmacology; D017209:Apoptosis; D015153:Blotting, Western; D002454:Cell Differentiation; D002455:Cell Division; D045744:Cell Line, Tumor; D018450:Disease Progression; D004583:Electrons; D005978:Glutathione / Q000378:metabolism; D006801:Humans; D000860:Hypoxia; D007150:Immunohistochemistry; D008175:Lung Neoplasms / Q000378:metabolism / Q000473:pathology*; D010084:Oxidation-Reduction; D018384:Oxidative Stress; D010544:Peroxidases / Q000096:biosynthesis*; D054464:Peroxiredoxins; D012313:RNA / Q000737:chemistry; D020133:Reverse Transcriptase Polymerase Chain Reaction; D013880:Thioredoxin-Disulfide Reductase / Q000096:biosynthesis; D013879:Thioredoxins / Q000096:biosynthesis*; D013997:Time Factors; D015854:Up-Regulation
chemical_list: D000975:Antioxidants; D013879:Thioredoxins; D012313:RNA; D010544:Peroxidases; D054464:Peroxiredoxins; D013880:Thioredoxin-Disulfide Reductase; D005978:Glutathione